1. Introduction {#sec1}
===============

Infections preceding the ischemic stroke (IS), as well as infections occurring in the acute phase of IS, are a frequent phenomenon \[[@B1], [@B2]\]. Chronic infections of both viral and bacterial etiology and coexistent vascular inflammatory state promote atherosclerosis, contributing to an increased cerebrovascular risk \[[@B3], [@B4]\]. The association of prestroke acute infectious events, in particular, respiratory tract infections, with increased risk of stroke \[[@B5]\], especially of cardioembolic and atherothrombotic etiology, was reported \[[@B2], [@B6]\]. Some authors suggest that prestroke infections are related not only to the risk but also to IS severity \[[@B7], [@B8]\]. On the other hand, stroke severity and lesion location are associated with the risk of in-hospital (post-stroke) infections. For example, patients with brainstem or diffuse cerebral lesions characterize with an increased risk of respiratory tract infection, that frequently results from dysphagia \[[@B9], [@B10]\]. It seems possible that post-stroke infectious events are favoured by the stroke-induced immunodepression \[[@B2]\].

The impact of post-stroke infections on IS outcome is the next important issue \[[@B11]\]. Some authors describe an association of post-stroke infections with poor patients\' outcome \[[@B12]--[@B14]\].

According to the presented data, a proper treatment of stroke-related infections may improve patients\' outcome. Until now some reports suggest that therapy with antibiotics in the acute phase of stroke (even in patients without the obvious signs of infection) reduces cerebral ischemia and improves the outcome \[[@B15], [@B16]\]. However, these observations were not confirmed by other studies \[[@B17], [@B18]\]. Some authors hypothesized that the use of antibiotics or vaccines before stroke onset may improve outcome \[[@B19]\].

The aims of our study were to investigate the prevalence of prestroke (occurring during 7 days before hospital admission) and post-stroke (in-hospital) infections among IS patients hospitalized in our stroke unit, as well as to analyse the impact of infections on stroke severity and the outcome, in terms of mortality and dependency during 3 months after IS.

2. Methods {#sec2}
==========

We analyzed the clinical data of patients hospitalized in our department between June 1, 1995 and August 31, 2005. The registry included 2066 consecutive patients admitted to the hospital with symptoms of acute IS. IS was diagnosed according to the World Health Organization definition as rapidly developed clinical signs of cerebral function disturbance lasting for more than 24 hours, of a vascular origin \[[@B20]\]. Brain imaging (CT, computed tomography or MRI, magnetic resonance imaging) was performed to confirm the diagnosis of IS. Information about stroke risk factors and clinical data was collected according to the modified Stroke Data Bank NINCDS protocol \[[@B21]\] including data on: age and gender, history of hypertension, diabetes, atrial fibrillation, coronary artery disease (CAD), heart failure and stroke, nicotine use during last 5 years, premorbid handicap status (dependency), neurological status on admission, etiology of IS, clinical stroke syndromes, volume of ischemic lesion, as well as infectious events during 7 days before admission, occurrence of pneumonia, and urinary tract infection (UTI) during hospitalization and the use of antibiotics during hospitalization.

Baseline neurological status and premorbid functional impairment were evaluated using the Scandinavian Stroke Scale (SSS) (score 0--58) \[[@B22]\] and modified Rankin Scale (mRS) (score 0--5) \[[@B23]\].

Information about prestroke factors was obtained during direct interview with patients. In case of unconscious, drowsy, or demented patients, their close relatives were interviewed. The information was supported by medical reports, if available. The history of prestroke infection included reported signs of an acute infectious disease (such as cold, fever, cough, or dysuria), medical reports on such a condition, as well as the use of antibacterial, antiviral, or supportive therapy and laboratory findings obtained during preceding 7 days that were typical for an acute infection. In our database information on the type of prestroke infection, as well as on classes of antibiotics used prior to IS, is not collected, thus, we did not analyse such data.

The etiology of IS was determined according to the criteria developed for the Trial of Org 10172 in Acute Stroke Treatment \[[@B24]\] on the basis of results of extra- and intracranial arteries ultrasonography, echocardiography, and electrocardiography. The five categories of IS were isolated according to etiology, that is, (1) large artery atherosclerosis, (2) cardioembolism, (3) small artery occlusion, (4) other determined etiology, and (5) unknown or multiple etiologies. In addition, using clinical criteria of the Oxfordshire Community Stroke Project (OCSP) based on neurological signs and syndromes, subtypes of IS were classified into total anterior circulation infarction (TACI), partial anterior circulation infarction (PACI), lacunar (LACI) and posterior circulation infarction (POCI) \[[@B25]\].

The diagnosis of pneumonia during hospitalization was established according to the CDC criteria for hospital-acquired pneumonia \[[@B26]\], on a basis of clinical and laboratory indices of respiratory tract infection (fever, cough, auscultatory changes, purulent tracheal secretions, positive sputum culture), supported by typical chest X-ray findings. The in-hospital UTI was diagnosed on a basis of leukocyturia present in the urine examination and positive urine culture (significant bacteriuria ≥ 10^5^/mL with isolation of a pathogen), supported by clinical symptoms, such as dysuria, urgency, or fever \[[@B26]\].

The SSS and mRS assessments were repeated at discharge or (if patient needed longer hospitalization) at the 30th day of hospital stay. The mRS score was also assessed 90 days after stroke.

The short-term (assessed at discharge or at the 30th day of hospital stay) and long-term (assessed 90 days after IS onset) outcomes were analysed. The outcome measurements included (1) mortality; (2) death or dependency (mRS ≥ 3). Poor outcome was defined as death or death/dependency. In case of death within 90 days from the hospital admission, the date and reason were registered. The following causes of death were registered in the studied group: neurological complications (IS or recurrent stroke), cardiogenic reasons or pulmonary embolus, infectious complications, and others, not related to stroke.

2.1. Statistical Analysis {#sec2.1}
-------------------------

The groups of patients with or without the history of prestroke infection were compared in terms of prevalence of IS risk factors, premorbid handicap level (mRS), baseline clinical characteristics (IS etiology according to the TOAST criteria, clinical syndromes determined by the OCSP criteria, neurological status determined by the SSS score, body temperature recorded during first 24 hours, and 7 days mean body temperature). The groups of patients were also compared for stroke recurrence during hospitalization, for 30-day neurological status, as well as for short-term and long-term outcome. Similar comparisons was made between the groups of patients, in whom pneumonia or UTI were diagnosed after IS, and without any concomitant (prestroke) infection.

The impact of prestroke and post-stroke infections on the short-term and long-term outcome (in terms of death and death/dependency) was investigated.

Categorical variables were compared by the use of Pearson *χ* ^2^ test. The normality of continuous variables was determined by the Kolmogorow-Smirnov test. Normally distributed continuous variables were compared using the Student\'s *t*-test, and continuous variables with not normal distribution were compared with the Mann-Whitney *U* test.

The mRS and SSS were evaluated by the *χ* ^2^ test, after dichotomizing the scales into categories: 0--2 and 3--5 points for the mRS, 0--25 and 26--58 points for the SSS, as it was accepted in previous studies \[[@B27], [@B28]\].

For the outcome measures (short- and long-term death and death/dependency) we did the Pearson *χ* ^2^ tests to evaluate differences between analysed groups. The logistic regression was used to assess a predictive value of prestroke and post-stroke infections for the outcome. Logistic regression analyses were performed, with adjustment for baseline and clinical variables. Variables that were significantly associated with a given outcome in univariate analysis were further included in the multivariate models. The odds ratios with 95% confidence intervals were used to estimate the magnitude of each factor effect.

Results were thought statistically significant when the *P* value was lower than  .05. Statistical analyses were performed using SPSS for Windows software, version 13.

3. Results {#sec3}
==========

Among 1950 patients for whom the necessary data was available, 111 (5.7%) had a history of an acute infection during 7 days before hospital admission.

Patients who suffered from an infectious disease prior to IS onset were characterized by older age, higher prevalence of heart failure, as well as by worse neurological status on hospital admission ([Table 1](#tab1){ref-type="table"}). The prestroke infection was not related to the type of IS according to the TOAST criteria, nor to the volume of brain ischemic lesion. Patients with infection preceding stroke onset were characterized by poorer short- and long-term outcome in terms of death as well as of death/dependency, compared with those without infection ([Table 1](#tab1){ref-type="table"}).

30.6% versus 15.3% of patients with versus without prestroke infection, respectively, died during 30 days after stroke onset; the percentage of patients with/without prestroke infection who died within 90 days was 41.1%/25.2%, respectively. The poor short-term outcome in terms of death/dependency was noticed in 68.5% of patients with and in 52.9% of patients without prestroke infection; the poor long-term outcome was observed in 61.4% of patients with infection and in 49.1% of patients without prestroke infection ([Table 1](#tab1){ref-type="table"}).

Among individuals with prestroke infection who died during the first 30 days the cardiogenic cause of death was diagnosed more frequently than in patients without infection (36.7% and 19.1%, resp.; *P* = .033).

Logistic regression analysis revealed that the history of prestroke infection was an independent predictor of poor short-term outcome in terms of death and of death/dependency ([Table 3](#tab3){ref-type="table"}); the prestroke infection was not a significant predictor of long-term outcome.

We observed a higher frequency of in-hospital infections (pneumonia or UTI) in patients, who suffered from any infection during 7 days prior to hospital admission, compared to the group without prestroke infection (58.6% versus 33.7%, resp.); *P* \< .001. About 81% of patients with any prestroke infection developed in-hospital pneumonia.

During hospitalization, nosocomial pneumonia was diagnosed in 403 (19.5% of 2066) patients and UTI in 482 (23.3%) patients; in 154 (7.5%) patients both infections were diagnosed.

368 (91.3%) patients with pneumonia, 441 (91.5%) patients with UTI, and 133 (86.4%) with both conditions, all with a negative history of prestroke infection, were further analysed.

Patients with in-hospital infection (pneumonia or UTI, *n* = 619) were characterized by older age, higher percentage of females, more frequent history of stroke, atrial fibrillation, heart failure, CAD and diabetes, than patients without diagnosed infection ([Table 2](#tab2){ref-type="table"}). The post-stroke pneumonia or UTI developed in patients that were characterized by worse premorbid functional status and by worse neurological status on admission. The in-hospital infections occurred more frequently in patients presenting with TACI and with ischemic lesions occupying at least one lobe of the brain ([Table 2](#tab2){ref-type="table"}).

In-hospital pneumonia more frequently developed among patients with dysphagia (92; 86.8% of 106 patients), than in those without swallowing difficulties (267; 48.2% of 554 patients); (*P* \< .001).

In patients with in-hospital infection (pneumonia or UTI) the cardioembolic etiology of stroke was diagnosed more often; lacunar strokes were diagnosed less frequently, compared to patients without an infection ([Table 2](#tab2){ref-type="table"}).

The in-hospital infection was associated with a worse neurological status assessed at hospital discharge/30 days after admission; it was also related to worse short-term and long-term outcome in terms of death and of death/dependency ([Table 2](#tab2){ref-type="table"}).

We observed no influence of in-hospital infections on the prevalence of recurrent stroke during the hospitalization.

The regression analysis was performed to assess the impact of pneumonia, UTI, or of both coexisting conditions, on patients\' outcome (Tables [4](#tab4){ref-type="table"} and [5](#tab5){ref-type="table"}). The in-hospital pneumonia was independently associated with the risk of poor short-term and long-term outcome. The in-hospital UTI was independently associated with poor short- and long-term outcome in terms of death/dependency; however it was surprisingly associated with lower short-term mortality. Patients with coexistent pneumonia and UTI had an increased risk of poor short- and long-term outcomes in terms of death and of death/dependency (Tables [4](#tab4){ref-type="table"} and [5](#tab5){ref-type="table"}).

The mean body temperature recorded during the first 24 hours after admission was significantly higher in the group of patients suffering from an acute infection in the preceding week ([Table 1](#tab1){ref-type="table"}). The body temperature at the first day after admission was significantly higher in patients with TACI, than in patients with other clinical syndromes (36.8°C ± 0.6 versus 36.7°C ± 0.4, resp.; *P* \< .001); the same was noticed when the mean body temperature in the first 7 days after hospital admission was compared between patients\' groups with TACI or with other clinical syndromes (37.1°C ± 0.4 versus 36.8°C ± 0.3, resp.; *P* \< .001).

In the regression analysis, increased temperature at the first day of hospital stay was a predictor of increased risk of death during 30 days in the group of patients with pneumonia and UTI coexisting; it was also a predictor of higher risk of short-term death/dependency in all groups of patients analysed (with pneumonia, UTI or with both infections) ([Table 4](#tab4){ref-type="table"}).

The increased mean week body temperature was an independent predictor of poor short-term and long-term outcomes in all groups of patients analysed (Tables [4](#tab4){ref-type="table"} and [5](#tab5){ref-type="table"}).

In 365 (91.0%) patients with in-hospital pneumonia antibiotics were used during hospitalization. In this group of patients, antibacterial therapy had no significant impact on prognosis during the follow-up period. Among patients with UTI, 391 (81.8%) were treated with antibiotics. In this group, antibacterial therapy was related to poor 30-day outcome (in terms of death/dependency) that was noticed in 75.5% of the treated compared to 61.2% of not treated patients (*P* = .029).

Among 343 patients (16.6% of 2066), who died within the 30-day period, 83 (28.4%) died due to infective complications such as pneumonia or sepsis. The other causes of death were neurological, cardiogenic or unrelated to stroke. The presence of in-hospital pneumonia, or UTI was not related to death etiology. Patients with coexisting pneumonia and UTI more frequently died because of infectious complications, and less often because of neurological complications, than those without these infections. The treatment with antibiotics did not determine the cause of death in patients with pneumonia, with UTI, as well as with both conditions.

4. Discussion {#sec4}
=============

We provide evidence that prestroke and post-stroke infections are independent predictors of poor IS outcome. This finding is consistent with other reports, which demonstrated the unfavourable impact of nosocomial infections, especially pneumonia, on short-term \[[@B13]\] and long-term stroke outcome \[[@B14], [@B29]\]. In our study the prestroke infection had an adverse effect on early outcome, with no effect on long-term prognosis, while the unfavourable effect of in-hospital infections (especially of pneumonia and UTI coexisting) was observed up to 90 days after the IS.

Some authors revealed that an association exists between prestroke respiratory infections and atherothrombotic and cardioembolic etiology of IS, as well as with more severe neurological deficit \[[@B30]\]. In the current study we confirmed an unfavourable effect of prestroke infections on neurological impairment; however, we did not confirm a relationship between prestroke infection and IS etiology.

The association of infarct volume with in-hospital infections, particularly the respiratory tract infection, has been previously described \[[@B31]\]. In the current study we have observed a similar relationship: patients with in-hospital pneumonia or UTI were characterized by more diffuse ischemic lesions (occupying at least one lobe or TACI). The relationship between lesion location and respiratory tract infection was also noticed: pneumonia occured more frequently in patients with dysphagia caused by brainstem or diffuse hemispheric stroke, as it was observed by previous authors \[[@B9], [@B10]\].

It was evidenced that high body temperature during first 24 hours after stroke onset is associated with large brain damage \[[@B32]\]. In our population increased body temperature during the first 7 days of hospital stay was associated with TACI and diffuse ischemic lesions. The increased body temperature during the first week of hospitalization was independently related to worse short-term and long-term outcome, even after adjustment for in-hospital infection. These findings lead to the conclusion that increased body temperature during the acute phase of IS should be reduced as soon as possible, in order to improve patients\' prognosis.

It seems interesting that, in the analysed group of IS patients, the highest risk of developing pneumonia or UTI during hospitalization was noticed in older females as well as in patients with coexisting cardiovascular risk factors like atrial fibrillation, heart failure, CAD, and diabetes, as well as in those with a history of prestroke infection. It suggests that such patients require a particularly careful prevention and early detection of infectious diseases.

When analysing the antibacterial treatment in the studied population, our results are not optimistic. The therapy with antibiotics during hospitalization in patients with pneumonia had no significant impact on the outcome. In the group of patients with UTI, an unfavourable effect of antibacterial treatment on short-term outcome (death/dependency) was observed. It seems surprising; however, it may be probably partially explained by the fact that UTI occurs often in patients catheterised, so in a worse global condition. The lack of favourable effect of antibacterial therapy on IS outcome indicates that prophylaxis of nosocomial pneumonia or UTI is important, as it may improve patients\' outcome.

We acknowledge that our study has several limitations. First, we did not analyse the pre- and post-stroke antibacterial therapy in detail (including the type of antibiotics, dose, and duration of treatment, as well as the time of implementation of antibiotics after IS onset). When considering post-stroke antibacterial treatment, typically, in our department, in patients with symptoms of pneumonia the antibiotics of wide therapeutical spectrum are used and then, after detection of the pathogen, specific classes of antibiotics are implemented. However, it could not be excluded that some patients might have pneumonia of the viral etiology, but because of their poor condition they were also treated with antibiotics. It might potentially influence our findings concerning the effects of antibacterial therapy.

Furthermore, when analyzing the impact of prestroke infections on the outcome, we focused on acute infection symptoms present during the 7 days before stroke onset. It is obvious that infections potentially related to stroke can occur up to several weeks prior to stroke onset; however, the major effect on stroke risk seems to have infections occuring during the preceding week \[[@B33]\].

5. Conclusions {#sec5}
==============

Pre- and post-stroke infections, particularly those occurring during hospitalization, are associated with a worse IS prognosis. The increase of body temperature during first 7 days after IS, even in patients without detected infection, has an adverse impact on their short-term and long-term outcome. The treatment with antibiotics during hospitalization in IS patients has no evident beneficial effect; this issue should be further investigated. The importance of prevention of pneumonia and UTI in patients with IS should be emphasized.
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###### 

Characteristics of patients with or without prestroke infection.

  Characteristics                       Prestroke infection (*n* = 111)   No prestroke infection (*n* = 1839)   *P*                   
  ------------------------------------- --------------------------------- ------------------------------------- ------- ------------- --------
  *N*                                   Value                             *N*                                   Value                 
                                                                                                                                      
  *Baseline characteristics*                                                                                                          
  Age, mean, SD (years)                 111                               74.6 ± 11.8                           1834    71.5 ± 12.3   .010
  Gender (male), *n* (%)                111                               49 (44.1)                             1839    843 (45.8)    .769
  Premorbid mRS 3--5, *n* (%)           111                               17 (15.3)                             1833    178 (9.7)     .071
  History of stroke, *n* (%)            110                               18 (16.4)                             1818    283 (15.6)    .788
  Hypertension, *n* (%)                 109                               74 (67.9)                             1830    1353 (73.9)   .179
  Atrial fibrillation, *n* (%)          110                               30 (27.3)                             1824    513 (28.1)    .913
  Heart failure, *n* (%)                109                               37 (33.9)                             1814    417 (23.0)    .014
  CAD, *n* (%)                          110                               43 (39.1)                             1825    646 (35.4)    .473
  Diabetes, *n* (%)                     111                               25 (22.5)                             1823    397 (21.8)    .814
  Nicotine use (5 years), *n* (%)       107                               21 (19.6)                             1822    476 (26.1)    .141
  Etiology of IS (TOAST)                111                                                                     1839                  
   Atherothrombotic, *n* (%)            16 (14.4)                         291 (15.8)                            .789                  
   Cardioembolic, *n* (%)               28 (25.2)                         484 (26.3)                            .912                  
   Lacunar, *n* (%)                     16 (14.4)                         343 (18.7)                            .313                  
  Diffuse lesion (≥1 lobe)              82                                33 (40.2)                             1110    384 (34.6)    .337
  TACI, *n* (%)                         110                               26 (23.6)                             1830    306 (16.7)    .068
  Admission SSS, mean, SD               111                               29.2 ± 18.0                           1836    34.0 ± 17.3   .008
  Body temperature day 1, mean (°C)     100                               36.8 ± 0.58                           1724    36.7 ± 0.43   .033
  Mean week body temperature (°C)       80                                36.9 ± 0.34                           1432    36.8 ± 0.36   .038
                                                                                                                                      
  *Outcome*                                                                                                                           
  Recurrent stroke, *n* (%)             111                               1 (0.9)                               1837    29 (1.6)      .573
  30-day SSS, mean, SD                  80                                43.9 ± 13.9                           1564    46.1 ± 13.4   .157
  30-day mortality, *n* (%)             111                               34 (30.6)                             1839    281 (15.3)    \<.001
  30-day death or dependency, *n* (%)   111                               76 (68.5)                             1809    957 (52.9)    .002
  90-day mortality, *n* (%)             95                                39 (41.1)                             1601    404 (25.2)    .001
  90 day death or dependency, *n* (%)   88                                54 (61.4)                             1514    743 (49.1)    .028

*N*: the number of patients with available data; SD: standard deviation; mRS: modified Rankin Scale; CAD: coronary artery disease; TACI: total anterior circulation infarction; IS: ischemic stroke; TOAST: Trial of Org 10172 in Acute Stroke Treatment; SSS: Scandinavian Stroke Scale.

###### 

Characteristics of patients with or without an in-hospital infection.

  Characteristics                       Pneumonia or UTI (*n* = 619)   No infection (*n* = 1219)   *P*                    
  ------------------------------------- ------------------------------ --------------------------- -------- ------------- --------
  *N*                                   Value                          *N*                         Value                  
                                                                                                                          
  *Baseline characteristics*                                                                                              
  Age, mean, SD (years)                 618                            76.1 ± 10.6                 1215     69.2 ± 12.4   \<.001
  Gender (male), *n* (%)                619                            201 (32.5)                  1219     641 (52.6)    \<.001
  Premorbid mRS 3--5, *n* (%)           616                            95 (15.4)                   1216     83 (6.8)      \<.001
  History of stroke, *n* (%)            614                            114 (18.6)                  1203     169 (14.0)    .014
  Hypertension, *n* (%)                 614                            456 (74.3)                  1215     896 (73.7)    .822
  Atrial fibrillation, *n* (%)          613                            234 (38.2)                  1210     279 (23.1)    \<.001
  Heart failure, *n* (%)                604                            193 (32.0)                  1209     223 (18.4)    \<.001
  CAD, *n* (%)                          613                            247 (40.3)                  1211     398 (32.9)    .002
  Diabetes, *n* (%)                     613                            158 (25.8)                  1209     239 (19.8)    .004
  Nicotine use (5 years), *n* (%)       615                            125 (20.3)                  1206     351 (29.1)    \<.001
  Etiology of IS (TOAST)                616                                                        1213                   
   Atherothrombotic, *n* (%)            93 (15.1)                      114 (9.4)                   .543                   
   Cardioembolic, *n* (%)               209 (33.9)                     275 (22.7)                  \<.001                 
   Lacunar, *n* (%)                     61 (9.9)                       282 (23.2)                  \<.001                 
  Diffuse lesion (≥1 lobe)              408                            211 (51.7)                  701      173 (24.7)    \<.001
  TACI, *n* (%)                         616                            192 (31.2)                  1213     114 (9.4)     \<.001
  Admission SSS, mean, SD               617                            23.4 ± 16.1                 1218     39.3 ± 15.4   \<.001
  Body temperature day 1, mean (°C)     574                            36.8 ± 0.52                 1149     36.7 ± 0.37   \<.001
  Mean week body temperature (°C)       616                            36.9 ± 1.27                 1208     36.7 ± 0.79   \<.001
                                                                                                                          
  *Outcome*                                                                                                               
  Recurrent stroke, *n* (%)             619                            14 (2.3)                    1219     15 (1.2)      .113
  30-day SSS, mean, SD                  424                            36.7 ± 15.9                 1139     49.6 ± 10.3   \<.001
  30-day mortality, *n* (%)             619                            192 (31.0)                  1219     89 (7.3)      \<.001
  30-day death or dependency, *n* (%)   599                            504 (84.1)                  1209     453 (37.5)    \<.001
  90-day mortality, *n* (%)             534                            274 (51.3)                  1066     130 (12.2)    \<.001
  90-day death or dependency, *n* (%)   502                            405 (80.7)                  1011     338 (33.4)    \<.001

UTI: urinary tract infection; *N*: the number of patients with available data; SD: standard deviation; mRS: modified Rankin Scale; CAD: coronary artery disease; TACI: total anterior circulation infarction; IS: ischemic stroke; TOAST: Trial of Org 10172 in Acute Stroke Treatment; SSS: Scandinavian Stroke Scale.

###### 

Logistic regression for poor 30-days outcome (prestroke infection).

                           Variables               OR             95% CI         *P*
  ------------------------ ----------------------- -------------- -------------- ------
  Death                    *Prestroke infection*   2.086          1.323--3.288   .002
  Age                      1.036                   1.023--1.050   \<.001         
  Gender (male)            0.934                   0.709--1.230   .627           
  mRS 3--5 before stroke   1.191                   1.078--1.317   .001           
  Heart failure            2.038                   1.516--2.740   \<.001         
  Atrial fibrillation      1.413                   1.065--1.876   .017           
  Diabetes mellitus        1.296                   0.963--1.745   .087           
  CAD                      0.912                   0.688--1.208   .519           
                                                                                 
  Death or dependency      *Prestroke infection*   1.635          1.044--2.560   .032
  Age                      1.027                   1.018--1.037   \<.001         
  Gender (male)            0.807                   0.657--0.992   .041           
  mRS 3--5 before stroke   1.963                   1.728--2.230   \<.001         
  History of stroke        0.904                   0.666--1.227   .519           
  Heart failure            1.198                   0.916--1.566   .187           
  Atrial fibrillation      1.345                   1.053--1.716   .017           
  Diabetes mellitus        1.231                   0.962--1.574   .098           
  CAD                      1.081                   0.865--1.351   .492           

OR: odds ratio; CI: confidence interval; mRS: modified Rankin Scale; CAD: coronary artery disease.

###### 

Logistic regression for poor 30-day outcome (in-hospital infections).

                           Variables     Pneumonia       UTI             Pneumonia and UTI                                                              
  ------------------------ ------------- --------------- --------------- ------------------- --------------- -------- -------- --------------- -------- -----
                                         OR              95% CI          *P*                 OR              95% CI   *P*      OR              95% CI   *P*
                                                                                                                                                        
  Death                    *Pneumonia*   5.422           3.684--7.979    \<.001              ---             ---      ---      ---             ---      ---
  *UTI*                    ---           ---             ---             0.551               0.353--0.859    .009     ---      ---             ---      
  *Pneumonia and UTI*      ---           ---             ---             ---                 ---             ---      2.275    1.454--3.559    \<.001   
  Age                      1.028         1.012--1.044    \<.001          1.038               1.022--1.054    \<.001   1.037    1.021--1.052    \<.001   
  Gender (male)            0.850         0.605--1.194    .350            0.912               0.656--1.266    .581     0.987    0.711--1.371    .939     
  mRS 3--5 before stroke   1.699         1.093--2.641    .018            1.652               1.073--2.543    .023     1.598    1.043--2.450    .031     
  Heart failure            2.197         1.527--3.162    \<.001          2.079               1.463--2.954    \<.001   2.018    1.419--2.870    \<.001   
  Atrial fibrillation      1.143         0.806--1.623    .453            1.206               0.861--1.688    .276     1.193    0.850--1.673    .307     
  Diabetes mellitus        1.093         0.757--1.576    .636            1.108               0.775--1.584    .574     1.108    0.776--1.583    .574     
  CAD                      0.865         0.611--1.225    .415            0.875               0.625--1.224    .435     0.856    0.612--1.198    .365     
  Body temperature day 1   1.413         0.968--2.061    .073            1.384               0.958--2.000    .083     1.467    1.017--2.117    .041     
  Mean week temperature    3.528         2.376--5.238    \<.001          4.906               3.334--7.219    \<.001   3.963    2.663--5.898    \<.001   
                                                                                                                                                        
  Death or dependency      *Pneumonia*   12.467          6.449--24.102   \<.001              ---             ---      ---      ---             ---      ---
  *UTI*                    ---           ---             ---             2.125               1.536--2.942    \<.001   ---      ---             ---      
  *Pneumonia and UTI*      ---           ---             ---             ---                 ---             ---      20.615   6.385--66.562   \<.001   
  Age                      1.027         1.017--1.038    \<.001          1.032               1.022--1.042    \<.001   1.032    1.022--1.042    \<.001   
  Gender (male)            0.700         0.556--0.882    .002            0.847               0.674--1.063    .152     0.783    0.624--0.981    .034     
  mRS 3-5 before stroke    17.244        8.495--35.004   \<.001          16.536              7.998--34.187   \<.001   16.854   8.295--34.241   \<.001   
  Heart failure            1.301         0.960--1.763    .090            1.282               0.952--1.727    .102     1.252    0.926--1.693    .145     
  Atrial fibrillation      1.152         0.875--1.515    .313            1.185               0.907--1.548    .213     1.138    0.868--1.492    .348     
  Diabetes mellitus        1.288         0.978--1.696    .071            1.265               0.966--1.657    .088     1.309    0.997--1.719    .052     
  CAD                      1.147         0.894--1.472    .281            1.104               0.864--1.412    .428     1.142    0.891--1.462    .294     
  Body temperature day 1   1.963         1.391--2.772    \<.001          1.895               1.348--2.665    \<.001   1.937    1.380--2.719    \<.001   
  Mean week temperature    2.262         1.648--3.105    \<.001          2.946               2.089--4.155    \<.001   2.288    1.636--3.200    \<.001   

OR: odds ratio; CI: confidence interval; mRS: modified Rankin Scale; CAD: coronary artery disease.

###### 

Logistic regression for poor 90-day outcome (in-hospital infections).

  ------------------------ ------------- --------------- --------------- ------------------ --------------- -------- ------- --------------- -------- -----
                           Variables     Pneumonia       UTI             Pneumonia or UTI                                                             
                                         OR              95% CI          *P*                OR              95% CI   *P*     OR              95% CI   *P*
                                                                                                                                                      
  Death                    *Pneumonia*   4.345           2.876--6.564    \<.001                                                                       
  *UTI*                                                                  0.756              0.513--1.116    .159                                      
  *Pneumonia and UTI*                                                                                                5.730   3.399--9.660    \<.001   
  Age                      1.043         1.028--1.058    \<.001          1.049              1.034--1.064    \<.001   1.048   1.033--1.063    \<.001   
  Gender (male)            0.973         0.716--1.322    .861            1.040              0.770--1.404    .800     1.089   0.804--1.477    .582     
  mRS 3--5 before stroke   2.122         1.365--3.299    .001            2.055              1.328--3.180    .001     2.063   1.328--3.204    .001     
  Heart failure            2.121         1.503--2.993    \<.001          2.036              1.452--2.853    \<.001   1.928   1.362--2.730    \<.001   
  Atrial fibrillation      1.357         0.984--1.870    .062            1.406              1.029--1.921    .032     1.367   0.992--1.884    .056     
  Diabetes mellitus        1.030         0.735--1.443    .865            1.042              0.748--1.451    .808     1.029   0.733--1.443    .870     
  CAD                      0.944         0.687--1.297    .724            0.942              0.690--1.286    .706     0.955   0.694--1.315    .778     
  Body temperature day 1   1.128         0.770--1.654    .536            1.076              0.738--1.568    .704     1.175   0.799--1.729    .413     
  Mean week temperature    7.338         4.801--11.216   \<.001          10.079             6.595--15.401   \<.001   6.766   4.367--10.485   \<.001   
                                                                                                                                                      
  Death or dependency      *Pneumonia*   8.700           4.743--15.956   \<.001                                                                       
  *UTI*                                                                  1.517              1.066--2.158    .020                                      
  *Pneumonia and UTI*                                                                                                8.940   3.975--20.108   \<.001   
  Age                      1.035         1.023--1.047    \<.001          1.039              1.028--1.051    \<.001   1.039   1.027--1.051    \<.001   
  Gender (male)            0.769         0.596--0.992    .043            0.902              0.702--1.159    .419     0.851   0.663--1.092    .205     
  mRS 3--5 before stroke   8.850         4.648--16.852   \<.001          8.206              4.287--15.707   \<.001   8.515   4.468--16.228   \<.001   
  Heart failure            1.309         0.941--1.820    .110            1.284              0.930--1.774    .129     1.206   0.868--1.677    .264     
  Atrial fibrillation      1.259         0.937--1.692    .127            1.275              0.956--1.700    .099     1.241   0.926--1.664    .148     
  Diabetes mellitus        1.350         1.005--1.813    .046            1.344              1.007--1.794    .045     1.362   1.016--1.826    .039     
  CAD                      1.235         0.939--1.626    .131            1.205              0.920--1.576    .175     1.252   0.954--1.644    .105     
  Body temperature day 1   1.226         0.838--1.794    .295            1.207              0.834--1.748    .318     1.306   0.898--1.899    .162     
  Mean week temperature    3.250         2.151--4.908    \<.001          4.521              2.969--6.886    \<.001   3.238   2.114--4.962    \<.001   
  ------------------------ ------------- --------------- --------------- ------------------ --------------- -------- ------- --------------- -------- -----

OR: odds ratio; CI: confidence interval; mRS: modified Rankin Scale; CAD: coronary artery disease.

[^1]: Academic Editor: Alexander Dressel
